Phase III data supported setmelanotide's recent label expansion in acquired hypothalamic o ...

(Nasdaq: BIIB), announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for a once-weekly lecanemab-irmb subcutaneous injection ...

Blinding diseases caused by the degeneration of photoreceptors, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), affect ...

LEQEMBI IQLIK is a first-of-its-kind anti-amyloid treatment worldwide, offering at-home dosing for initiation and maintenance (approved in the U.S.) U.S. launch of LEQEMBI IQLIK as an initiation dose ...

Insilico Medicine, an AI-based drug developer whose profile within biopharma has risen with its recent collaborations with ...

Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational ...

Snakes keep rodents out of your crops, balance entire ecosystems, and their venom saves human lives, yet nearly half of Americans feel anxious just looking at one. The fear runs deep, but so does the ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

An exploration of autonomous AI agents as non-human identities, why classic risk models fail, and how zero-trust, guardrails, ...

A PNG hiding a prompt injection could steal your repo's secrets, researchers demonstrate. The technique, dubbed 'Ghostcommit, ...

Prompt injections, the malicious commands attackers embed into content to entice LLMs to follow them, have been attackers’ go ...

The Space Force added a new weapon to its arsenal, a device designed to blast electromagnetic beams to silence adversary ...